Form 4: Maravai LifeSciences CFO Kevin Herde Reports Stock Transaction
SEC Form 4 Filing
Kevin Herde, CFO of Maravai LifeSciences Holdings, Inc., reports the disposal of 8,624 shares of Class A Common Stock to cover tax obligations.
Summary
- On March 15, 2024, Kevin Herde, the Chief Financial Officer of Maravai LifeSciences Holdings, Inc., disposed of 8,624 shares of Class A Common Stock.
- The transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock units.
- The price per share was $7.7.
- Following the transaction, Herde directly owns 332,914 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, so it doesn't significantly impact sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vested stock, which is a common occurrence.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of stock transaction |
| 03/18/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.